Coronary Stents Market : Technology Advancements, Application & Growth Analysis by 2022

Coronary artery stent is a small elastic tube used in the treatment of narrow coronary arteries and occluded coronary arteries in patients with coronary artery disease (CAD). These reduce the symptoms of chest pain (angina pectoris) and help to treat heart attacks. This type of stent is also called a heart stent or a heart stent. They are implanted into contracted coronary arteries, including a metal mesh, and known as percutaneous coronary intervention (PCI) or pulcutaneous coronary intervention (PCI).

The global market was valued at $4,806 million in 2015, and is projected to reach at $9,003 million by 2022, growing at a CAGR of 9.5% from 2016 to 2022. The drug-eluting stents (DES) segment accounted for nearly half of the total market in 2015.

Get Sample Copy of Report @ https://www.alliedmarketresearch.com/request-sample/2187?utm_source=openpr&utm_medium=ss

The leading factors in the growth of the global coronary artery stent market are increased CAD prevalence, improved patient outcomes of stenting, and the emergence of new trends in the field of coronary artery stenting. There is also an opportunity for coronary stent manufacturers with increased demand for coronary stents in emerging countries and increased awareness of the availability of appropriate insurance and reimbursement policies. However, the cost of coronary stent-related procedures and the availability of alternative methods for CAD treatment are expected to hamper market growth.

Key Players:
• Meril Life Sciences Pvt. Ltd.
• Vascular Concepts Limited
• Translumina GmbH
• REVA MedicalInc.
• Elixir Medical Corporation.

Get Detailed Enquiry on this Report @ https://www.alliedmarketresearch.com/purchase-enquiry/2187?utm_source=openpr&utm_medium=ss

DES is expected to maintain its dominant position during the analysis period due to the important characteristics that prevent the growth of scar tissue (restenosis) in the arterial wall after surgery. In addition, the development of the stent field has greatly improved DES and reduced stent thrombosis. It also provides improved results for CAD patients treated with percutaneous coronary intervention (PCI).

The Metallic Biomaterials segment accounted for three-quarters of the market in 2015 with the cost-effectiveness of this material. Metallic biomaterials provide the benefits of vascular healing compared to other materials. They are used to make inflatable and drug-eluting stents. The worldwide market for metallic biocompatible materials is expected to grow at a CAGR of 9.5%.

Key Findings of the Coronary Stents Market Study:

•The bio-absorbable stents are anticipated to grow at a highest rate during the analysis period from 2016 to 2022.
•Asia-Pacific is projected to maintain its lead position throughout 2022, growing at a CAGR of 11.5%.
•The metallic biomaterial segment occupied more than half of the total market in 2015.
•China occupied one-fourth of the share of the total Asia-Pacific coronary stents market in 2015.
•India is expected to grow at the highest CAGR of 14.2% from 2016 to 2022

Browse More Information of Report @ https://www.alliedmarketresearch.com/coronary-stents-market?utm_source=openpr&utm_medium=ss

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.
Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.